TAM
Taurus Asset Management’s Regeneron Pharmaceuticals REGN Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q1 | $10.6M | Sell |
16,711
-414
| -2% | -$263K | 1.07% | 35 |
|
|
2024
Q4 | $12.2M | Buy |
17,125
+1,130
| +7% | +$805K | 1.19% | 32 |
|
|
2024
Q3 | $16.8M | Sell |
15,995
-46
| -0.3% | -$48.4K | 1.64% | 30 |
|
|
2024
Q2 | $16.9M | Buy |
16,041
+134
| +0.8% | +$141K | 1.71% | 27 |
|
|
2024
Q1 | $15.3M | Sell |
15,907
-147
| -0.9% | -$141K | 1.55% | 31 |
|
|
2023
Q4 | $14.1M | Sell |
16,054
-73
| -0.5% | -$64.1K | 1.52% | 29 |
|
|
2023
Q3 | $13.3M | Sell |
16,127
-80
| -0.5% | -$65.8K | 1.61% | 29 |
|
|
2023
Q2 | $11.6M | Sell |
16,207
-706
| -4% | -$507K | 1.35% | 30 |
|
|
2023
Q1 | $13.9M | Sell |
16,913
-20,226
| -54% | -$16.6M | 1.7% | 26 |
|
|
2022
Q4 | $26.8M | Sell |
37,139
-851
| -2% | -$614K | 3.4% | 8 |
|
|
2022
Q3 | $26.2M | Sell |
37,990
-5,850
| -13% | -$4.03M | 3.5% | 7 |
|
|
2022
Q2 | $25.9M | Sell |
43,840
-2,492
| -5% | -$1.47M | 3.2% | 10 |
|
|
2022
Q1 | $32.4M | Sell |
46,332
-450
| -1% | -$314K | 3.26% | 10 |
|
|
2021
Q4 | $29.5M | Buy |
46,782
+290
| +0.6% | +$183K | 2.79% | 13 |
|
|
2021
Q3 | $28.1M | Sell |
46,492
-95
| -0.2% | -$57.5K | 2.93% | 12 |
|
|
2021
Q2 | $26M | Buy |
46,587
+425
| +0.9% | +$237K | 2.72% | 13 |
|
|
2021
Q1 | $21.8M | Buy |
+46,162
| New | +$21.8M | 2.52% | 16 |
|